持续气道正压通气治疗对阻塞性睡眠呼吸暂停综合征患者血清IL-6和hs-CRP水平影响(3)
http://www.100md.com
2010年9月1日
 |
| 第1页 |
参见附件(1598KB，2页)。
[5]Htipoglu U,Rubinstein I.Inflammation and obstructive sleep apnea syndrome pathogenesis:a working hypothesis.Respiration,2003,70(6):665-671.
[6]Libby P,Ridker PM,Maseri A.Inflammation and atherosclerosis[J].Circulation,2002,105(9):1135-1136.
[7]Cesari M,Pennnix B W,Newman A B,et al.inflammation markers and onset of cardiovascular events:results from the Health ABC study[J].Circulation,2003,108:2317-2322.
[8]Rifai N.High sensitivity Creactive protein:a usefulmarker for cardiovascular disease risk prediction and the metabolic syndrome[J].Clin Chem,2005,51(3):50425.
[9]Yudkin JS,Kumari M,Humphries SE,et al.Inflammation,obesity,stress and coronary heart disease:is interleukin-6 the link?Atherosclerosis,2000,148:209-214.
[10]Kawai T.Inflammatory markers,especially the mechanism of increased CRP[J].Rinsho Byori,2000,48(8):719-211.
[11]Hatipoglu U,Rubinstein I.Inflammation and obstructive sleep apnea syndrome pathogenesis:a working hypothesis.Respiration,2003,70(6):665-671.
[12]Patel SR,White DP,Malhotra A,et al.Continuous positive airway pressure therapy for treating sleepiness in a diverse population with obstructive sleep apnea:results of a meta-analysis.Arch Intern Med,2003,163:565-571.
[13]Malhotra A,Ayas NT,Epstein LJ.The art and science of continuous positive airway pressure therapy in obstructive sleep apnea.Curr Opin Pulm Med,2000,6:490-495.
您现在查看是摘要介绍页，详见PDF附件(1598KB，2页)。